Table 2.
All (N = 1587) | Males (N = 243) | Females (N = 1344) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
T-Score (L1–L4 Spine) | T1 | T2 | T3 | p | T1 | T2 | T3 | p | T1 | T2 | T3 | p |
Central Obesity | 66.9 | 79.8 | 82.7 | <0.01 | 38.3 | 60.5 | 71.6 | <0.01 | 72.1 | 83.4 | 84.7 | <0.01 |
Hyperglycemia | 69.9 | 73.8 | 74.0 | 0.25 | 86.4 | 80.2 | 91.4 | 0.12 | 66.9 | 72.7 | 70.8 | 0.16 |
Low HDL-Cholesterol | 63.0 | 64.6 | 68.5 | 0.17 | 40.7 | 45.7 | 42.0 | 0.80 | 67.1 | 68.1 | 73.3 | 0.09 |
Hypertriglyceridemia | 40.3 | 46.2 | 47.7 | 0.04 | 54.3 | 58.0 | 64.2 | 0.43 | 37.7 | 44.0 | 44.6 | 0.07 |
Hypertension | 29.3 | 32.5 | 34.4 | 0.20 | 38.3 | 35.8 | 39.5 | 0.88 | 27.6 | 31.9 | 33.5 | 0.15 |
Full MetS | 56.1 | 63.3 | 67.6 | <0.01 | 50.6 | 60.5 | 71.6 | 0.02 | 57.1 | 64.4 | 65.8 | 0.003 |
Note: Data presented as frequency (%) for the components of MetS and full MetS. T1, T2 and T3 are the three tertiles of T-score (spine) whose respective values as median (Q1, Q3) are −2.70 (−3.1, −2.4), −1.65 (−1.9, −1.3) and –0.30 (−0.7, 0.4) for all participants; −2.20 (−2.7, −1.7), 0.80 (−1.2, −0.5) and 0.55 (0.1, 1.1) for males; –2.80 (−3.2, −2.5), –1.70 (−2.0, −1.5) and –0.40 (−0.8, 0.2) for females. Chi-squared test was used to check the differences of frequencies in different tertiles of T-score. p < 0.05 was considered significant. HDL, high density lipoprotein.